Tectonic therapeutic to present on december 3rd, 2024 at the piper sandler healthcare conference

Watertown, mass., nov. 26, 2024 (globe newswire) -- tectonic therapeutic, inc. (nasdaq: tecx) (tectonic), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of g-protein coupled receptors (gpcrs), today announced that alise reicin, md, president and chief executive officer, will present at the piper sandler 36th annual healthcare conference being held in new york on december 3-5, 2024.
TECX Ratings Summary
TECX Quant Ranking